2008
DOI: 10.1186/1475-2875-7-31
|View full text |Cite
|
Sign up to set email alerts
|

Sulphadoxine/pyrimethamine versus amodiaquine for treating uncomplicated childhood malaria in Gabon: A randomized trial to guide national policy

Abstract: Background: In Gabon, following the adoption of amodiaquine/artesunate combination (AQ/AS) as firstline treatment of malaria and of sulphadoxine/pyrimethamine (SP) for preventive intermittent treatment of pregnant women, a clinical trial of SP versus AQ was conducted in a sub-urban area. This is the first study carried out in Gabon following the WHO guidelines.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
19
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 27 publications
(19 citation statements)
references
References 22 publications
0
19
0
Order By: Relevance
“…Data on the efficacy of sulfadoxine-pyrimethamine in children showed a therapeutic efficacy rate of 88.4% at day 28 in 2005. 10 This study was reviewed and approved by the Gabonese Ministry of Health.…”
Section: Methodsmentioning
confidence: 99%
“…Data on the efficacy of sulfadoxine-pyrimethamine in children showed a therapeutic efficacy rate of 88.4% at day 28 in 2005. 10 This study was reviewed and approved by the Gabonese Ministry of Health.…”
Section: Methodsmentioning
confidence: 99%
“…Furthermore, an increase of asexual parasites and gametocytes harboring the Pfmdr1 NFD haplotype in patients treated with AL was linked with treatment failure [19]. and the resistance to CQ, amodiaquine and sulfadoxinepyrimethamine is widespread [20][21][22][23]. In 2003, in line with WHO recommendations, the National Malaria Control Program adopted the ACT strategy to treat uncomplicated malarial spraying, instead of CQ and other monotherapies.…”
Section: Introductionmentioning
confidence: 98%
“…The ACTs most widely used in Gabon are artemether-lumefantrine (AL) and artesunate-amodiaquine (AS-AQ). Consequently, the prevalence of malaria among febrile children fell from 30% to 13% between 2004 and 2008, the mean age of children with malaria rose from 24 to 41 months [21,7]. Later, in 2013, several studies demonstrated the rise of malaria in urban areas of the country (Libreville, Oyem and Franceville) [24,25].…”
Section: Introductionmentioning
confidence: 99%
“…Data were collected from children aged six months to 10 years suffering from uncomplicated malaria who took part in two clinical trials performed between 2005 and 2006 as described elsewhere (Bouyou-Akotet et al, 2010;Nsimba et al, 2008). These patients were treated either with amodiaquine (AQ), sulfadoxinepyrimethamine (SP) or artesunate-mefloquine (AM) according to their age and/or weight following World Health Organization (WHO) guidelines.…”
Section: Study Populationmentioning
confidence: 99%